Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
637 | 13723 | 36.9 | 74% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TISSUE FACTOR | authKW | 1054385 | 7% | 46% | 1022 |
2 | THROMBOMODULIN | authKW | 557863 | 3% | 53% | 477 |
3 | PROTEIN C | authKW | 466301 | 3% | 45% | 470 |
4 | TISSUE FACTOR PATHWAY INHIBITOR | authKW | 395485 | 2% | 64% | 276 |
5 | ACTIVATED PROTEIN C | authKW | 334796 | 2% | 57% | 265 |
6 | ANTITHROMBIN | authKW | 301348 | 2% | 41% | 333 |
7 | PROTEIN S | authKW | 265387 | 2% | 45% | 268 |
8 | DISSEMINATED INTRAVASCULAR COAGULATION | authKW | 254468 | 2% | 33% | 343 |
9 | THROMBOSIS RESEARCH | journal | 243724 | 8% | 10% | 1060 |
10 | THROMBOSIS AND HAEMOSTASIS | journal | 231258 | 7% | 10% | 1019 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Hematology | 221597 | 39% | 2% | 5320 |
2 | Peripheral Vascular Diseases | 94501 | 25% | 1% | 3382 |
3 | Biochemistry & Molecular Biology | 7369 | 23% | 0% | 3118 |
4 | Critical Care Medicine | 3782 | 4% | 0% | 491 |
5 | Medical Laboratory Technology | 893 | 2% | 0% | 219 |
6 | Medicine, Research & Experimental | 845 | 4% | 0% | 568 |
7 | Biophysics | 582 | 4% | 0% | 482 |
8 | Medicine, General & Internal | 443 | 4% | 0% | 608 |
9 | Cardiac & Cardiovascular System | 293 | 3% | 0% | 439 |
10 | Pathology | 270 | 2% | 0% | 273 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CARDIOVASC BIOL PROGRAM | 62293 | 1% | 27% | 106 |
2 | U428 | 36953 | 0% | 41% | 41 |
3 | EDWARD A DOISY BIOCHEM MOL BIOL | 33393 | 1% | 18% | 85 |
4 | MOL BIOL ORAL DIS | 30284 | 0% | 26% | 52 |
5 | HAEMOSTASIS BIOCHEM | 28651 | 0% | 68% | 19 |
6 | REG HEMODONAC | 26292 | 0% | 30% | 40 |
7 | MOL PATHOBIOL | 21573 | 0% | 22% | 45 |
8 | TISSUE TOR TOR 7 | 20209 | 0% | 91% | 10 |
9 | VASC MED INTERNAL MED | 18956 | 0% | 53% | 16 |
10 | JOSEPH STOKES | 18898 | 0% | 43% | 20 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | THROMBOSIS RESEARCH | 243724 | 8% | 10% | 1060 |
2 | THROMBOSIS AND HAEMOSTASIS | 231258 | 7% | 10% | 1019 |
3 | BLOOD COAGULATION & FIBRINOLYSIS | 92806 | 3% | 11% | 371 |
4 | JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 60744 | 2% | 8% | 328 |
5 | SEMINARS IN THROMBOSIS AND HEMOSTASIS | 47741 | 2% | 9% | 239 |
6 | HAEMOSTASIS | 29725 | 1% | 10% | 129 |
7 | BLOOD | 23974 | 5% | 2% | 619 |
8 | CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS | 12667 | 1% | 6% | 97 |
9 | JOURNAL OF BIOLOGICAL CHEMISTRY | 12501 | 7% | 1% | 970 |
10 | BIOCHEMISTRY | 7638 | 3% | 1% | 447 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TISSUE FACTOR | 1054385 | 7% | 46% | 1022 | Search TISSUE+FACTOR | Search TISSUE+FACTOR |
2 | THROMBOMODULIN | 557863 | 3% | 53% | 477 | Search THROMBOMODULIN | Search THROMBOMODULIN |
3 | PROTEIN C | 466301 | 3% | 45% | 470 | Search PROTEIN+C | Search PROTEIN+C |
4 | TISSUE FACTOR PATHWAY INHIBITOR | 395485 | 2% | 64% | 276 | Search TISSUE+FACTOR+PATHWAY+INHIBITOR | Search TISSUE+FACTOR+PATHWAY+INHIBITOR |
5 | ACTIVATED PROTEIN C | 334796 | 2% | 57% | 265 | Search ACTIVATED+PROTEIN+C | Search ACTIVATED+PROTEIN+C |
6 | ANTITHROMBIN | 301348 | 2% | 41% | 333 | Search ANTITHROMBIN | Search ANTITHROMBIN |
7 | PROTEIN S | 265387 | 2% | 45% | 268 | Search PROTEIN+S | Search PROTEIN+S |
8 | DISSEMINATED INTRAVASCULAR COAGULATION | 254468 | 2% | 33% | 343 | Search DISSEMINATED+INTRAVASCULAR+COAGULATION | Search DISSEMINATED+INTRAVASCULAR+COAGULATION |
9 | PURPURA FULMINANS | 195140 | 1% | 73% | 120 | Search PURPURA+FULMINANS | Search PURPURA+FULMINANS |
10 | FACTOR VII DEFICIENCY | 161281 | 1% | 76% | 96 | Search FACTOR+VII+DEFICIENCY | Search FACTOR+VII+DEFICIENCY |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | CONWAY, EM , (2012) THROMBOMODULIN AND ITS ROLE IN INFLAMMATION.SEMINARS IN IMMUNOPATHOLOGY. VOL. 34. ISSUE 1. P. 107 -125 | 162 | 66% | 89 |
2 | BROZE, GJ , GIRARD, TJ , (2012) TISSUE FACTOR PATHWAY INHIBITOR: STRUCTURE-FUNCTION.FRONTIERS IN BIOSCIENCE-LANDMARK. VOL. 17. ISSUE . P. 262-280 | 139 | 89% | 38 |
3 | DAHLBACK, B , (1995) THE PROTEIN-C ANTICOAGULANT SYSTEM - INHERITED DEFECTS AS BASIS FOR VENOUS THROMBOSIS.THROMBOSIS RESEARCH. VOL. 77. ISSUE 1. P. 1-43 | 220 | 87% | 151 |
4 | WOOD, JP , ELLERY, PER , MARONEY, SA , MAST, AE , (2014) BIOLOGY OF TISSUE FACTOR PATHWAY INHIBITOR.BLOOD. VOL. 123. ISSUE 19. P. 2934 -2943 | 108 | 89% | 27 |
5 | CAMERER, E , KOLSTO, AB , PRYDZ, H , (1996) CELL BIOLOGY OF TISSUE FACTOR, THE PRINCIPAL INITIATOR OF BLOOD COAGULATION.THROMBOSIS RESEARCH. VOL. 81. ISSUE 1. P. 1 -41 | 184 | 74% | 300 |
6 | MONTES, R , PUY, C , MOLINA, E , HERMIDA, J , (2012) IS EPCR A MULTI-LIGAND RECEPTOR? PROS AND CONS.THROMBOSIS AND HAEMOSTASIS. VOL. 107. ISSUE 5. P. 815-826 | 122 | 93% | 12 |
7 | GRIFFIN, JH , ZLOKOVIC, BV , MOSNIER, LO , (2012) PROTEIN C ANTICOAGULANT AND CYTOPROTECTIVE PATHWAYS.INTERNATIONAL JOURNAL OF HEMATOLOGY. VOL. 95. ISSUE 4. P. 333-345 | 129 | 79% | 35 |
8 | WINCKERS, K , TEN CATE, H , HACKENG, TM , (2013) THE ROLE OF TISSUE FACTOR PATHWAY INHIBITOR IN ATHEROSCLEROSIS AND ARTERIAL THROMBOSIS.BLOOD REVIEWS. VOL. 27. ISSUE 3. P. 119 -132 | 122 | 82% | 24 |
9 | EILERTSEN, KE , OSTERUD, B , (2004) TISSUE FACTOR: (PATHO)PHYSIOLOGY AND CELLULAR BIOLOGY.BLOOD COAGULATION & FIBRINOLYSIS. VOL. 15. ISSUE 7. P. 521-538 | 167 | 78% | 68 |
10 | BOCK, PE , PANIZZI, P , VERHAMME, IMA , (2007) EXOSITES IN THE SUBSTRATE SPECIFICITY OF BLOOD COAGULATION REACTIONS.JOURNAL OF THROMBOSIS AND HAEMOSTASIS. VOL. 5. ISSUE . P. 81-94 | 130 | 88% | 76 |
Classes with closest relation at Level 2 |